Opendata, web and dolomites

PODIUM SIGNED

PODIUM™ - A home device and cloud-based software and algorithm for diabetic foot ulcer monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PODIUM project word cloud

Explore the words cloud of the PODIUM project. It provides you a very rough idea of what is the project "PODIUM" about.

generating    8m    85    2024    12    plus    dfu    cameras    premature    rate    subscription       small    serious    extremely    2015    unsuccessful    complications    9bn    uk    trade    imaging    diabetic       amputation    podium    sufferers    detection    suffering    qol    physicians    adults    290    5m       solutions    5bn    esters    foot    diagnosis    us    limb    pressure    cholesteric    roi    deaths    europeans    effectiveness    life    treatment    facilitated    2025    conventional    75    dramatically    risk    temperature    healthcare    convenience    decreasing    ulcer    sales    model    complication    diabetics    60m    monitoring    diabetes    456    solution    competitive    global    instead    caused    thermetrix    efficacy    1m    crystalline    amounting    introduction    mortality    market    10x    experiment    ulcers    improvement    revealed    grow    prevented    business    lower    mainly    amputations    23    diagnostic    450    24    sensitive    reported    reduce    cloud    suffer    validate    25    cagr    quality    liquid    threatening    lifetime    infrared    thermographs    savings    substantial    8bn    rapid    9m    consequence    dfus    sensitivity    considerable    percentage   

Project "PODIUM" data sheet

The following table provides information about the project.

Coordinator
THERMETRIX LTD. 

Organization address
address: TY MENTER NAVIGATION PARK SUITE 12
city: ABERCYNON
postcode: CF45 4SN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://podium.care/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THERMETRIX LTD. UK (ABERCYNON) coordinator 50˙000.00

Map

 Project objective

'There are 60m adults suffering from diabetes in Europe and 3.8m in UK (5m by 2025). Diabetes has a high mortality rate caused mainly by complications (75,000 deaths p.a., of which 24,000 are premature). One life-threatening complication of diabetes is a diabetic foot ulcer (DFU). Studies revealed a 12% to 25% lifetime risk of developing DFU for diabetics, meaning over 9m Europeans (c.456,000 to 1m in UK) might suffer from DFU in their lifetime. A serious consequence of DFU is lower limb amputation; 85% of the amputations in diabetes sufferers are reported after unsuccessful DFU treatment amounting to 290,000–450,000 amputations/year in Europe, at a cost of €2–2.5bn/year.

The PODIUM™ technology is a novel, extremely reliable and highly sensitive solution for the cost-effective diagnosis and monitoring of DFUs through rapid temperature imaging and reliable analysis of thermographs. PODIUM™ will result in increased numbers of prevented DFUs through 10X higher sensitivity than any competitive solutions. A timely response from physicians, facilitated by PODIUM™ could reduce DFU-related amputations and healthcare costs. Thermetrix’s technology will provide a considerable Quality of Life (QoL) improvement for users and enable substantial savings in healthcare even if only a very small percentage would adopt PODIUM™. The global DFU and pressure ulcers market is expected to grow from US$2.8bn in 2015 to US$4.9bn by 2024 (CAGR 6.6%).

The objectives of this project are (1) experiment with the introduction of liquid crystalline cholesteric esters instead of infrared-cameras as detection method (dramatically decreasing the cost of the method); (2) validate the higher efficacy, diagnostic value, convenience and cost-effectiveness of PODIUM™ over conventional approaches; and (3) validate the business model based on 'unit costs plus cloud subscription' with the aim of generating a ROI of 23:1 based only on European sales only.

'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PODIUM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PODIUM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

LTS (2020)

LEARNING TO SLEEP: INCREASING HEALTH THROUGH BETTER SLEEP

Read More